Global University Venturing

Max Planck Foundation joined the EIF and AWS as a limited partner in university-focused drug discovery fund Khan Technology Transfer Fund I.

Osage University Partners has celebrated an exit as migraine treatment developer Satsuma Pharmaceuticals listed on the Nasdaq Global Market following an $82.5m offering.

September started out with news on several life sciences companies about to go public as well as a large acquisition deal of another one of them. This space enjoyed a great number of exits last year and the trend appears on a path to be continued through 2019.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Trifacta, co-founded by Stanford and UC Berkeley researchers, has attracted nearly a dozen investors for a round that brought its total funding to $224m.

University of Arkansas Technology Ventures pushed forth with 47 invention disclosures in 2018-19, a 52% year-on-year rise.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Novartis and Novo helped provide $40m for the EPFL spinout that supported its acquisition of joint venture Kanyos Bio.

Annual turnover and invention disclosures at Satt Sud-Est fell as the TTO shifted its strategy in favour of deep tech applications and co-maturation agreements.

Ohio's state government has launched Ohio IP Promise, a standard set of intellectual property guidelines for academic research in the state.

The immuno-oncology drug developer, spun out of Johannes Gutenberg University Mainz, has filed for a $100m offering in the US.